BAX Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
3.0B
+0.5%
3.0B
+9.6%
2.7B
-9.2%
3.0B
+4.9%
2.8B
Cost of Revenue
2.0B
+2.8%
1.9B
+6.5%
1.8B
-24.5%
2.4B
+27.2%
1.9B
Gross Profit
994.0M
-3.7%
1.0B
+15.8%
891.0M
+54.4%
577.0M
-39.3%
950.0M
Operating Expenses
769.0M
-5.6%
815.0M
-1.2%
825.0M
-39.9%
1.4B
+76.3%
778.0M
R&D
125.0M
-3.1%
129.0M
-7.2%
139.0M
+10.3%
126.0M
+6.8%
118.0M
SG&A
730.0M
-0.7%
735.0M
+1.0%
728.0M
-4.3%
761.0M
+7.5%
708.0M
Operating Income
225.0M
+3.7%
217.0M
+228.8%
66.0M
+108.3%
-795000000
-562.2%
172.0M
EBITDA
464.0M
+1.8%
456.0M
+50.5%
303.0M
+532.9%
-70000000
-117.1%
409.0M
Net Income
294.0M
+133.3%
126.0M
+940.0%
-15000000
+98.6%
-1071000000
-2228.3%
-46000000
EPS (Basic)
$0.57
+137.5%
$0.24
+900.0%
$-0.03
+98.6%
$-2.09
-2222.2%
$-0.09
EPS (Diluted)
$0.57
+137.5%
$0.24
+900.0%
$-0.03
+98.6%
$-2.10
-2233.3%
$-0.09
Shares (Diluted)
520.0M
+0.4%
518.0M
+0.6%
515.0M
+1.0%
510.0M
-0.8%
514.0M
Baxter International (BAX) — Financials